Influenza Virus -Immunology and Genetics Features

Immunology is the branch of biomedical sciences concerned with all aspects of the immunological research in all multicellular organisms. Antiviral resistance in influenza may not only develop during treatment but also sometimes transmit widely to replace susceptible strains in the absence of drug pressure. Although instances of antiviral drug resistance among influenza viruses have occurred during antiviral therapy, resistant influenza strains have spread widely in the absence of such drug pressure. Influenza occurs in outbreaks and epidemics worldwide, mainly during the winter season. Although acutely debilitating, influenza is usually a self-limited infection; however, it is associated with increased morbidity and mortality in certain high-risk populations.

With the grand success of Vaccines Asia Pacific 2015 conference, Conference Series LLC is organizing the “5th Annual Congress on Influenza, Respiratory Diseases & Infections: Vaccines and Therapeutics (IRDI Vaccines 2016)” will be scheduled during December 01-02, 2016 at Atlanta, USA. IRDI Vaccines 2016 bring together the Global leaders in Immunology and relevant fields to present their research at this exclusive scientific program. IRDI Vaccines 2016 Organizing Committee also invites Young investigators at every career stage to submit abstracts reporting their latest scientific findings in oral and poster sessions.

Influenza is a contagious respiratory disease that causes symptoms similar to those of the seasonal influenza in people. Flu is caused by a virus. The most common subtype, or strain, is influenza type A H1N1, and this subtype has also caused infection in people. Influenza viruses are constantly changing their genes, a process called mutation. When a swine flu virus is found in humans, it is said to have "jumped the species barrier." This means that the virus has mutated in a way that allows it to cause the condition in humans. Because humans have no natural protection or immunity to the virus, they are likely to become ill.

With the grand success of Vaccines Asia Pacific 2015 conference, Conference Series LLC is organizing the “5th Annual Congress on Influenza, Respiratory Diseases & Infections: Vaccines and Therapeutics (IRDI Vaccines 2016)” will be scheduled during December 01-02, 2016 at Atlanta, USA. IRDI Vaccines 2016 bring together the Global leaders in Immunology and relevant fields to present their research at this exclusive scientific program. IRDI Vaccines 2016 Organizing Committee also invites Young investigators at every career stage to submit abstracts reporting their latest scientific findings in oral and poster sessions.  

 

  • The Biology of H1N1- Genome Structure
  • Influenza Virus and Strains
  • Influenza Antigenic Changes- A (H1N1) Immune Escape Mutants
  • Immuno Response
  • Antiviral Resistance
  • Evolution and Genetic Diversity

Related Conference of Influenza Virus -Immunology and Genetics Features

September 18-19, 2017

20th Global Summit & Expo on Vaccines, Immunization & B2B

(Global B2B Meetings in 1 Event) Houston, Texas USA
October 05-07, 2017

World Vaccines and Immunization Congress

Osaka, Japan
October 30-31, 2017

19th International Vaccines & B2B Congress

Chicago, USA

Influenza Virus -Immunology and Genetics Features Conference Speakers

Recommended Sessions

Related Journals

Are you interested in